Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04154878 · ClinicalTrials.gov registry record

2 New Measurements Used to Describe the Filling Phase of the Left Ventricle (LV).

A clinical trial, sponsored by AdventHealth.

Completed
Registry status
111
Enrollment target

NCT04154878 is a clinical trial that has completed, run by AdventHealth. The registered enrollment target is 111 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04154878 has completed, sponsored by AdventHealth.

COMPLETED
Registry status
111 participants
Enrollment target

Study Summary

As we live longer our population experiencing heart failure (HF) continues to grow consuming an increasing percent of healthcare dollars. Systolic heart failure or pump failure is easy to recognize and measure and is expressed as ejection fraction. Diastolic heart failure (DHF) or failure to fill adequately is much more difficult to quantify with no single measure or number being used to express the severity instead groupings are used with normal and Grade I, II or Grade III to classify with Grade III being the direst. Heart Failure with Reduced Ejection Fraction (HFrEF) and Heart Failure with Preserved Ejection Fraction (HFpEF) are used to identify the primary clinical presentation of HF but do not adequately describe the combined effect often presenting within the same subject. It is estimated 35 to 50% of those with HFrEF, having Left Ventricle Ejection Fraction (LVEF) \< 50%, and 50 to 70% of those with HFpEF, having ejection fraction ≥ 50%, also have moderate to severe diastolic dysfunction (DD). The purpose of this study is two fold. The first is to determine if the rate of change measured from the left ventricular inflow inspiratory phase Doppler waveform provides insight into a cause of diastolic heart failure by comparing echocardiographic data points obtained prior to and immediately following optimization of a bi-ventricular pacemaker. This HF population requires an ejection fraction of 35 percent or lower to qualify for the device. These echocardiograms have been previously completed and will be reanalyzed. The second purpose is to determine if relationships between different features of a LV volume curve can be used to generate a single number to describe global diastolic function using the same echocardiograms from the pacemaker group. Results will be compared to a small group of healthy normal participants as a control for validation.

Trial Details

FieldValue
Enrollment Target 111 participants
Start Date 2019-10-30
Est. Completion 2023-06-21

Sponsor

AdventHealth

95 total trials

What the Registry Record Tells You About NCT04154878

The ClinicalTrials.gov registry entry for NCT04154878 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT04154878 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04154878 about?

NCT04154878 is a clinical study titled "2 New Measurements Used to Describe the Filling Phase of the Left Ventricle (LV).". As we live longer our population experiencing heart failure (HF) continues to grow consuming an increasing percent of healthcare dollars. Systolic heart failure or pump failure is easy to recognize and measure and is expressed as ejection fraction. Diastolic heart failure (DHF) or failure to fill ad...

What is the current status of trial NCT04154878?

This trial is currently completed. The enrollment target is 111 participants. The study started on 2019-10-30. Estimated completion is 2023-06-21.

Who is sponsoring clinical trial NCT04154878?

This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.